6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis

Evangelia Xingi, Despina Smirlis, Vassilios Myrianthopoulos, Prokopios Magiatis, Karen M. Grant, Laurent Meijer, Emmanuel Mikros, Alexios‐Léandros Skaltsounis, Ketty Soteriadou

International Journal for Parasitology · 2009 · 74 citations · 32 references

DOIFull text

Open access

Concepts

References

32